Cedilla Therapeutics Competitors and Similar CompaniesClear all
AustinPx's competitors and similar companies include Clovis Oncology and Pharmacyclics.
 AustinPx AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules. |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2009 | Founding Date 1991 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Georgetown, US HQ | Locations Sunnyvale, US HQ | |
Employees | Employees 412% decrease | Employees 4843% increase | Employees 6551% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $729.7m (FY, 2014) |
Net income | Net income N/A | Net income ($264.5m) (FY, 2021) | Net income $86.1m (FY, 2014) |
Funding | |||
Total funding raised | Total funding raised $ 52.7m | Total funding raised $ 357m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company